Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
Clinical trial NCT00882414 · TERMINATED
Trial details
- NCT number
- NCT00882414
- Sponsor
- Vifor Pharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2010-01-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.